Middle East Healthcare Company
4009.SR
#6069
Rank
โ‚ฌ0.79 B
Marketcap
8,69ย โ‚ฌ
Share price
-1.04%
Change (1 day)
-51.51%
Change (1 year)

P/E ratio for Middle East Healthcare Company (4009.SR)

P/E ratio as of December 2025 (TTM): 10.7

According to Middle East Healthcare Company's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 10.6574. At the end of 2024 the company had a P/E ratio of 22.3.

P/E ratio history for Middle East Healthcare Company from 2016 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202422.3-95.27%
20234721415.14%
202231.1-81.15%
2021165314.12%
202039.946.02%
201927.359.98%
201817.113.43%
201715.0-13.17%
201617.3

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.